Invention Grant
US08901126B2 Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases
有权
取代的咪唑并[1,5-A]喹喔啉-4-酮可用于预防或治疗储存功能障碍，排尿功能障碍和膀胱/尿道疾病
![Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases](/docs/US/2014-12-02/US08901126B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases
- Patent Title (中): 取代的咪唑并[1,5-A]喹喔啉-4-酮可用于预防或治疗储存功能障碍，排尿功能障碍和膀胱/尿道疾病
-
Application No.: US13788770Application Date: 2013-03-07
-
Publication No.: US08901126B2Publication Date: 2014-12-02
- Inventor: Hiroyuki Kaizawa , Mari Sugita , Hirofumi Yamamoto , Kazunori Kamijo , Kazuyuki Tsuchiya , Ryushi Seo , Satoshi Yamamoto
- Applicant: Astellas Pharma Inc.
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2010-200402 20100907
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D241/38 ; C07D487/04 ; C07D519/00
![Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases](/abs-image/US/2014/12/02/US08901126B2/abs.jpg.150x150.jpg)
Abstract:
Substituted imidazo[1,5-a]quinoxalin-4-one compounds of formula (I) described herein exhibit PDE9-inhibitory action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like.
Public/Granted literature
- US20130296329A1 QUINOXALINE COMPOUND Public/Granted day:2013-11-07
Information query
IPC分类:
